Biosimilars Market Size, Share, and Forecast by 2028
Biosimilars Market: Size and Share
-
CAGR (2021 - 2028)34.8% -
Market Size 2021
US$ 18.44 Billion -
Market Size 2028
US$ 136.07 Billion
Market Dynamics
- Rising demand for biosimilars due to cost-effectiveness
- Expanding use of biosimilars in oncology and immunology
- Growing adoption of biosimilars
- Support for biosimilar approvals
- Adoption of biosimilars to lower healthcare costs
- Expansion into emerging markets with biosimilar drugs
Market Segmentation
Disease Indication - Cancer
- Diabetes
- Autoimmune Diseases
- Other Disease Indications
Drug Class - Granulocyte Colony-Stimulating Factor
- Insulin
- TNK Blockers & Monoclonal Antibodies
Route of Administration - Intravenous
- Subcutaneous
End User - Hospital
- Specialty Clinics
- Homecare
Biosimilars Market Players Density: Understanding Its Impact on Business Dynamics
The Biosimilars Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Biosimilars Market are:
- Biocon Ltd
- Sanofi-Aventis
- Celltrion Inc.
- Amgen Inc.
- Pfizer Inc.
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Biosimilars Market top key players overview
Get Free Sample For